Systematic review and meta-analysis of the baseline concentrations and physiologic responses of gut hormones to food in eating disorders

American Journal of Clinical Nutrition

Volumn 89, Issue 3, 2009, Pages 755-765

  Prince, Alexis C ^a   Brooks, Samantha J ^a   Stahl, Daniel ^a   Treasure, Janet ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLECYSTOKININ; GASTRIC INHIBITORY POLYPEPTIDE; GASTRIN; GASTROINTESTINAL HORMONE; GHRELIN; GLUCAGON; GLUCAGON LIKE PEPTIDE 1; INSULIN; PEPTIDE YY; SOMATOSTATIN; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANOREXIA NERVOSA; BODY MASS; BULIMIA; CONCENTRATION (PARAMETERS); CONTROL GROUP; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; EATING DISORDER; FOOD; GLUCOSE TOLERANCE TEST; HORMONE BLOOD LEVEL; HUMAN; OUTCOME VARIABLE; POSTPRANDIAL STATE; REVIEW; TEST MEAL;

CHOLECYSTOKININ; EATING DISORDERS; GASTROINTESTINAL HORMONES; GASTROINTESTINAL TRACT; GHRELIN; HUMANS; INSULIN; PANCREATIC POLYPEPTIDE; PEPTIDE YY;

EID: 61449245518     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.3945/ajcn.2008.27056     Document Type: Review

References (43)

1. Kaye W, Strober M. Neurobiology of eating disorders. In: Charney DS, Nestler EJ, Bunney BS. eds. Neurobiological foundations of mental illness. New York, NY: Oxford University Press, 1999:891-906.
2. Kaye WH. Neuropeptide abnormalities in anorexia nervosa. Psychiatry Res 1996;62:65-74.
3. Monteleone P, Castaldo E, Maj M. Neuroendocrine dysregulation of food intake in eating disorders. Regul Pept 2008;149:39-50.
4. Stoving RK, Hangaard J, Hansen-Nord M, Hagen C. A review of endocrine changes in anorexia nervosa. J Psychiatr Res 1999;33:139-52.
5. Gale SM, Castracane VD, Mantzoros CS. Energy homeostasis, obesity and eating disorders: recent advances in endocrinology. J Nutr 2004;134: 295-8.
6. Stanley S, Wynne K, McGowan B, Bloom S. Hormonal regulation of food intake. Physiol Rev 2005;85:1131-58.
7. Brown NW, Ward A, Surwit R, et al. Evidence for metabolic and endocrine abnormalities in subjects recovered from anorexia nervosa. Metabolism 2003;52:296-302.
8. Valevski A, Fridberg G, Gil-Ad I, Laron Z, Weizman A. Neuroendo-crinological response to standardized mixed meal in female anorectic patients during active and refeeding phases. J Pediatr Endocrinol Metab 2000;13:195-9.
9. Harty RF, Pearson PH, Solomon TE, McGuigan JE. Cholecystokinin, vasoactive intestinal peptide and peptide histidine methionine responses to feeding in anorexia nervosa. Regul Pept 1991;36:141-50.
10. Nedvidkova J, Krykorkova I, Bartak V, et al. Loss of meal-induced decrease in plasma ghrelin levels in patients with anorexia nervosa. J Clin Endocrinol Metab 2003;88:1678-82.
11. Casper RC, Pandy GN, Jaspan JB, Rubenstein AH. Hormone and metabolite plasma levels after oral glucose in bulimia and healthy controls. Biol Psychiatry 1988;24:663-74.
12. Tomasik PJ, Sztefko K, Malek A. GLP-1 as a satiety factor in children with eating disorders. Horm Metab Res 2002;34:77-80.
13. Tomasik PJ, Sztefko K, Starzyk J. Cholecystokinin, glucose dependent insulinotropic peptide and glucagon-like peptide 1 secretion in children with anorexia nervosa and simple obesity. J Pediatr Endocrinol Metab 2004;17:1623-31.
14. Pirke KM, Friess E, Kellner MB, Krieg JC, Fichter MM. Somatostatin in eating disorders. Int J Eat Disord 1994;15:99-102.
15. Bradburn MJ, Deeks JJ, Altman DG. sbe24: METAN-an alternative meta-analysis command. Stata Tech Bull 1998;44:1-15.
16. Wilson DB. Effect size determination program. College Park, MD: University of Maryland, 2001.
17. Cooper HM, Hedges LV. The handbook of research synthesis. New York, NY: Russell Sage Foundation, 1994.
18. Everitt B. Modern medical statistics: a practical guide. London, United Kingdom: Arnold, 2003.
19. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.
20. Monteleone P, Martiadis V, Fabrazzo M, Serritella C, Maj M. Ghrelin and leptin responses to food ingestion in bulimia nervosa: implications for binge-eating and compensatory behaviours. Psychol Med 2003;33: 1387-94.
21. Kojima S, Nakahara T, Nagai N, et al. Altered ghrelin and peptide YY responses to meals in bulimia nervosa. Clin Endocrinol (Oxf) 2005;62:74-8.
22. Monteleone P, Martiadis V, Rigamonti AE, et al. Investigation of peptide YY and ghrelin responses to a test meal in bulimia nervosa. Biol Psychiatry 2005;57:926-31.
23. Tanaka M, Tatebe Y, Nakahara T, et al. Eating pattern and the effect of oral glucose on ghrelin and insulin secretion in patients with anorexia nervosa. Clin Endocrinol (Oxf) 2003;59:574-9.
24. Misra M, Miller KK, Herzog DB, et al. Growth hormone and ghrelin responses to an oral glucose load in adolescent girls with anorexia nervosa and controls. J Clin Endocrinol Metab 2004;89:1605-12.
25. Otto B, Tschop M, Fruhauf E, et al. Postprandial ghrelin release in anorectic patients before and after weight gain. Psychoneur- oendocrinology 2005;30:577-81.
26. Stock S, Leichner P, Wong AC, et al. Ghrelin, peptide YY, glucose-dependent insulinotropic polypeptide, and hunger responses to a mixed meal in anorexic, obese, and control female adolescents. J Clin Endocrinol Metab 2005;90:2161-8.
27. Nakahara T, Kojima S, Tanaka M, et al. Incomplete restoration of the secretion of ghrelin and PYY compared to insulin after food ingestion following weight gain in anorexia nervosa. J Psychiatr Res 2007;41: 814-20.
28. Otto B, Cuntz U, Otto C, Heldwein W, Riepl RL, Tschop MH. Peptide YY release in anorectic patients after liquid meal. Appetite 2007;48: 301-4.
29. Geracioti TD Jr, Liddle RA. Impaired cholecystokinin secretion in bulimia nervosa. N Engl J Med 1988;319:683-8.
30. Devlin MJ, Walsh BT, Guss JL, Kissileff HR, Liddle RA, Petkova E. Postprandial cholecystokinin release and gastric emptying in patients with bulimia nervosa. Am J Clin Nutr 1997;65:114-20.
31. Keel PK, Wolfe BE, Liddle RA, De Young KP, Jimerson DC. Clinical features and physiological response to a test meal in purging disorder and bulimia nervosa. Arch Gen Psychiatry 2007;64:1058-66.
32. Phillipp E, Pirke KM, Kellner MB, Krieg JC. Disturbed cholecystokinin secretion in patients with eating disorders. Life Sci 1991;48:2443-50.
33. Fujimoto S, Inui A, Kiyota N, et al. Increased cholecystokinin and pancreatic polypeptide responses to a fat-rich meal in patients with restrictive but not bulimic anorexia nervosa. Biol Psychiatry 1997;41: 1068-70.
34. Tomasik PJ, Sztefko K, Starzyk J, Rogatko I, Szafran Z. Entero-insular axis in children with anorexia nervosa. Psychoneuroendocrinology 2005;30:364-72.
35. Geracioti TD Jr, Liddle RA, Altemus M, Demitrack MA, Gold PW. Regulation of appetite and cholecystokinin secretion in anorexia nervosa. Am J Psychiatry 1992;149:958-61.
36. Tamai H, Takemura J, Kobayashi N, Matsubayashi S, Matsukura S, Nakagawa T. Changes in plasma cholecystokinin concentrations after oral glucose tolerance test in anorexia nervosa before and after therapy. Metabolism 1993;42:581-4.
37. Uhe AM, Szmukler GI, Collier GR, Hansky J, O'Dea K, Young GP. Potential regulators of feeding behavior in anorexia nervosa. Am J Clin Nutr 1992;55:28-32.
38. Gniuli D, Liverani E, Capristo E, Greco AV, Mingrone G. Blunted glucose metabolism in anorexia nervosa. Metabolism 2001;50:876-81.
39. Kinzig KP, Coughlin JW, Redgrave GW, Moran TH, Guarda AS. Insulin, glucose, and pancreatic polypeptide responses to a test meal in restricting type anorexia nervosa before and after weight restoration. Am J Physiol Endocrinol Metab 2007;292:E1441-6.
40. Geiger BM, Behr GG, Frank LE, et al. Evidence for defective mesolimbic dopamine exocytosis in obesity-prone rats. FASEB J 2008;22:2740-6.
41. Batterham RL, Ffytche DH, Rosenthal JM, et al. PYY modulation of cortical and hypothalamic brain areas predicts feeding behaviour in humans. Nature 2007;450:106-9.
42. Kishi T, Elmquist JK. Body weight is regulated by the brain: a link between feeding and emotion. Mol Psychiatry 2005;10:132-46.
43. Lutter M, Sakata I, Osborne-Lawrence S, et al. The orexigenic hormone ghrelin defends against depressive symptoms of chronic stress. Nat Neurosci 2008;11:752-3.